Genital Herpes: What It Is, Symptoms, Treatment &…

By Melissa Renae RDN HealthDay Reporter>TUESDAY, March 14, 2023 -- Genital herpes. It's an embarrassing sexually transmitted disease that no one ever wants to be diagnosed with, but millions are. According to the U.S. Centers…

U.S. to Tighten Control of PFAS Chemicals in…

By Cara Murez HealthDay Reporter>TUESDAY, March 14, 2023 -- U.S. water utilities will be required to remove certain “forever chemicals” from drinking water as the Biden administration sets first-ever limits on perfluoroalkyl and polyfluoroalkyl compounds,…

FDA Approves First Treatment for Rett Syndrome

News Consumer News FDA Approves First Treatment for Rett Syndrome By Lori Solomon HealthDay Reporter>TUESDAY, March 14, 2023 – The U.S. Food and Drug Administration has approved Daybue (trofinetide) for the treatment of Rett syndrome…

Most Americans With Medical Debt Owe Money to…

By Cara Murez HealthDay Reporter>TUESDAY, March 14, 2023 -- When Americans have medical debt, it’s typically to a hospital, according to new research. The Urban Institute found that more than 15% of non-elderly adults in…

Drug Used in Pregnancies in 1960s, 70s May…

By Cara Murez HealthDay Reporter>TUESDAY, March 14, 2023 -- The children of women who took a common anti-nausea drug for pregnancy in the 1960s and 1970s may be at higher risk of colon cancer, according…

A Good Nights Sleep Could Give Your Vaccine…

By Cara Murez HealthDay Reporter>TUESDAY, March 14, 2023 -- It may be possible to nudge your vaccine to work a little better. The trick is a good night’s sleep. Sleep helps the immune system respond…

After 3 Years of the Pandemic, Loneliness May…

By Cara Murez HealthDay Reporter>TUESDAY, March 14, 2023 -- On the third anniversary of the pandemic, a new poll shows fewer older adults are experiencing loneliness and isolation though the numbers are still high. About…

Zavzpret Nasal Spray Approved to Treat Migraines

News Consumer News Zavzpret Nasal Spray Approved to Treat Migraines By Physician’s Briefing Staff HealthDay Reporter>MONDAY, March 13, 2023 -- The U.S. Food and Drug Administration has approved Pfizer's zavegepant (Zavzpret), a calcitonin gene-related peptide…